BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 8767533)

  • 1. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
    Notario A; Rolandi ML; Mazzucchelli I
    Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
    Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
    Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia.
    Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC
    Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
    Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T
    Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
    Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM
    Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor in acute myeloid leukemia.
    Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
    Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of acute promyelocytic leukemia--combined use of all-trans retinoic acid and granulocyte colony-stimulating factor].
    Tsurumi H; Yamada T; Sawada M; Nakamura N; Takahashi T; Moriwaki H; Muto Y
    Rinsho Ketsueki; 1995 Jun; 36(6):582-8. PubMed ID: 7543953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans retinoic acid as a single agent induces complete remission in a patient with acute leukemia of M2a subtype.
    Chen Z; Wang Y; Wang W; Gong J; Xue Y
    Chin Med J (Engl); 2002 Jan; 115(1):58-61. PubMed ID: 11930660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
    Dubois C; Schlageter MH; de Gentile A; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L
    Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complete remission induced by combined treatment with all-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) in a patient with relapsed acute promyelocytic leukemia].
    Wakayama T; Furuya H; Takagi C; Ichiba S; Kato Y
    Rinsho Ketsueki; 1994 Nov; 35(11):1315-21. PubMed ID: 7529843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
    Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
    Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of priming with granulocyte macrophage colony-stimulating factor plus all-trans retinoic acid combined with remission induction chemotherapy in patients with acute myeloid leukemia.
    Shin HJ; Chung JS; Choi YJ; Cho GJ
    Am J Clin Oncol; 2009 Jun; 32(3):227-32. PubMed ID: 19433969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment with combination of all-trans retinoic acid (ATRA) and rhG-CSF a relapsed acute promyelocytic leukemia with umbilical tumor].
    Abe Y; Takatsuki H; Okada Y; Yufu Y; Kimura T; Nishimura J; Nawata H; Oshima K; Kikuchi M
    Rinsho Ketsueki; 1996 Dec; 37(12):1395-9. PubMed ID: 8997128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF-induced remission in two cases of acute myeloid leukemia.
    Benz R; Goede JS; Parlier V; Mühlematter D; Jotterand M; Fehr J
    Leuk Res; 2008 Jul; 32(7):1148-52. PubMed ID: 18166225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.
    Bug G; Ritter M; Wassmann B; Schoch C; Heinzel T; Schwarz K; Romanski A; Kramer OH; Kampfmann M; Hoelzer D; Neubauer A; Ruthardt M; Ottmann OG
    Cancer; 2005 Dec; 104(12):2717-25. PubMed ID: 16294345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of growth sensitivity of acute promyelocytic leukemia cells to granulocyte colony-stimulating factor using 7AAD/PY during administration of all-trans retinoic acid.
    Toba K; Koike T; Wang Y; Nagai K; Takahashi H; Hashimoto S; Uesugi Y; Aizawa Y
    Int J Hematol; 1997 Aug; 66(2):203-12. PubMed ID: 9277051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
    Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.